Detalles de la búsqueda
1.
Results from a preclinical study in rodents and a Phase 1/2, randomized, double-blind, placebo-controlled, parallel-group study of COVID-19 vaccine S-268019-a in Japanese adults.
Vaccine
; 41(11): 1834-1847, 2023 03 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36572603
2.
Non-Omicron breakthrough infection with higher viral load and longer vaccination-infection interval improves SARS-CoV-2 BA.4/5 neutralization.
iScience
; 26(2): 105969, 2023 Feb 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-36687316
3.
A lethal mouse model for evaluating vaccine-associated enhanced respiratory disease during SARS-CoV-2 infection.
Sci Adv
; 8(1): eabh3827, 2022 Jan 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34995117
4.
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathology.
Vaccine
; 40(41): 5892-5903, 2022 09 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-36064667
5.
Vaccination-infection interval determines cross-neutralization potency to SARS-CoV-2 Omicron after breakthrough infection by other variants.
Med
; 3(4): 249-261.e4, 2022 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35261995
6.
Structure-Guided Creation of an Anti-HA Stalk Antibody F11 Derivative That Neutralizes Both F11-Sensitive and -Resistant Influenza A(H1N1)pdm09 Viruses.
Viruses
; 13(9)2021 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-34578314
Resultados
1 -
6
de 6
1
Próxima >
>>